Prurigo Nodularis: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Space

DelveInsight’s Prurigo Nodularis market report overview of pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies

DelveInsight’s “ Prurigo Nodularis Market Insights” report delivers an in-depth understanding of the Prurigo Nodularis, historical & forecasted epidemiology, as well as the Prurigo Nodularis market trends in the 7MM (the United States EU5 (Germany, Spain, Italy, France, and United Kingdom) & Japan) for the study period 2018-30.

Some of the key highlights from the Prurigo Nodularis market insights

• The total diagnosed Prurigo Nodularis prevalent population in the 7MM was approx 5,00,000 in 2018
• The United States had the largest share in the diagnosed prevalent patient population
• According to DelveInsight’s analysis, females are affected more as compared to males.
• Major Players such as Menlo Therapeutics, Trevi Therapeutics, Galderma, Amgen, Maruho, Kiniksa Pharmaceuticals and Sanofi/Regeneron Pharmaceuticals involved in developing therapies for the treatment and management of Prurigo Nodularis Market
• Key Prurigo Nodularis pipeline therapies includes Serlopitant, Nalbuphine ER, Nemolizumab (CD14152), Apremilast (CC-10004), M 118103, KPL-716, Dupixent (Dupilumab/SAR231893) and many others

Request for sample for deep insights into Prurigo Nodularis Market @ Prurigo Nodularis Market Report

Prurigo Nodularis Overview

Prurigo nodularis (PN) is an intensely pruritic, chronic skin condition characterized by localized or generalized hyperkeratotic papules and nodules typically in a symmetrical distribution. PN is accompanied by long-standing pruritus and is thought to develop as a reaction to repeated scratching in patients with Chronic Prurigo (CP) from various etiologies, including dermatological, systemic, infectious, and psychiatric.

Prurigo Nodularis Epidemiology Segmentation in the 7MM for the Study period 2018-2030

• Diagnosed Prevalent cases
• Gender-specific Diagnosed Prevalence
• Age-specific Diagnosed Prevalence
• Type-specific Diagnosed Prevalence
• Severity-Specific Diagnosed Prevalence

Visit here for more information @ Prurigo Nodularis Epidemiology Segmentation

Prurigo Nodularis Market

The market for Prurigo Nodularis in the United States is anticipated to increase by 2030, and the major reason for the market upsurge will be the launch of anticipated therapies.

Prurigo Nodularis Key Players

• Menlo Therapeutics
• Trevi Therapeutics
• Galderma
• Amgen
• Maruho
• Kiniksa Pharmaceuticals
• Sanofi/Regeneron Pharmaceuticals
• And many others

Prurigo Nodularis Pipeline Therapies

• Serlopitant
• Nalbuphine ER
• Nemolizumab (CD14152)
• Apremilast (CC-10004)
• M 118103
• KPL-716
• Dupixent (Dupilumab/SAR231893)
• And many other

Prurigo Nodularis Market Report Key Strengths

• 10 Forecast
• 7MM Coverage
• Prurigo nodularis (PN) Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake

Prurigo Nodularis Key Questions Answered in the report

• What was the Prurigo Nodularis market share distribution in 2017 and how it would look like in 2030?
• What would be the Prurigo Nodularis market size as well as market size by therapies across the 7MM during the forecast period (2020–2030)?
• What are the key findings pertaining to the market across the 7MM and which country will have the largest Prurigo Nodularis market size during the forecast period (2020–2030)?
• At what CAGR, the Prurigo Nodularis (PN) market is expected to grow at the 7MM level during the forecast period (2020–2030)?
• What would be the Prurigo Nodularis (PN) market outlook across the 7MM during the forecast period (2020–2030)?
• What would be the Prurigo Nodularis (PN) market growth till 2030 and what will be the resultant market size in the year 2030?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Please speak to our expert here @ Prurigo Nodularis Market Report

Table of content

1 Key Insights

2 Prurigo nodularis (PN): Patient Overview at a Glance

3 Executive Summary

4 SWOT Analysis

5 Disease Background and Overview of Prurigo nodularis (PN)

6 Recognized Establishments

7 Epidemiology and Patient Population: Prurigo nodularis (PN)

8 Country-wise Epidemiology of Prurigo nodularis

9 Treatment

10 European Guidelines on PN

11 FDA Recommendations for PN Treatment

12 Unmet Need

13 Emerging Drugs

14 Market Size: Prurigo Nodularis

15 Attribute Analysis

16 Conjoint Analysis

17 7MM Market Outlook

18 EU5 Countries

19 Japan

20 Case Reports

21 Market Drivers

22 Market Barriers

23 Appendix

24 Report Methodology

25 DelveInsight Capabilities

26 Disclaimer

27 About DelveInsight

Get to know about report @ Prurigo Nodularis Market Outlook

Related Reports

Abscess Market

DelveInsight’s Abscess Market Insights, Epidemiology and Market Forecast 2030

Acne Vulgaris Market

DelveInsight’s Acne Vulgaris Market Insights, Epidemiology and Market Forecast – 2030

Actinic Keratosis Market

DelveInsight’s Actinic Keratosis Market Insights, Epidemiology and Market Forecast 2030

Basal Cell Carcinoma Market

DelveInsight’s Basal Cell Carcinoma Market Insights, Epidemiology and Market Forecast – 2030

Blepharitis Market

DelveInsight’s Blepharitis Market Insights, Epidemiology and Market Forecast – 2030

Candidiasis Market

DelveInsight’s Candidiasis Market Insights, Epidemiology and Market Forecast – 2030

Visit on our blog section

• Actinic Keratosis A Warning Sign for Potential Skin Cancer
• Acne Vulgaris Market Outlook | DelveInsight Business Research

About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.  

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve

For more insights into Pharma industry, Visit Pharma, Healthcare and Biotech Blog

Contact Information:

Shruti Thakur
info@delveinsight.com
+91-9650213330